Efficacy of Sotorasib Versus Standard Chemotherapy plus Immunotherapy in KRAS G12C Mutated Lung Cancer: A Comparative Study Modeling Real-World Data

被引：0
|
作者：
Haddad, P. [1 ]
Hammoud, D. [1 ]
机构：
[1] Louisiana State Univ, Overton Brooks VAMC, Hlth Sci Ctr, Overton, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.41
引用
收藏
页码：E28 / E28
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety outcomes in patients receiving sotorasib for advanced KRAS G12C-mutated non-small cell lung cancer
    Milner-Watts, Charlotte
    O'Sullivan, Hazel
    Stewart, James
    Idaikkadar, Praveena
    Tokaca, Nadza
    Davidson, Michael
    Yousaf, Nadia
    Bhosle, Jaishree
    Popat, Sanjay
    O'Brien, Mary
    Minchom, Anna
    LUNG CANCER, 2023, 178 : S31 - S32
  • [32] Real-world treatment pattern and clinical outcome in Chinese NSCLC patients with KRAS G12C mutation
    Shen, L.
    Song, Z.
    Yin, Y.
    Lei, Y.
    Lu, S.
    ANNALS OF ONCOLOGY, 2024, 35
  • [33] Anti-KRAS G12C and Anti-EGFR Rechallenge in Chemotherapy-Refractory KRAS G12C-Mutated Colorectal Cancer: A Case Report
    Morris, Linda
    Pappas, Leontios
    Pandey, Aditya
    Singh, Harshabad
    Klempner, Samuel
    Caughey, Bennett
    JCO PRECISION ONCOLOGY, 2024, 8
  • [34] Clinical Characteristics and Outcomes in Patients With KRAS G12C Mutated Non-Small Cell Lung Cancer
    Pellini, B.
    Ganesan, V.
    Wan, F.
    Sankararaman, S.
    Manyanont, S.
    Akhave, N.
    Baggstrom, M.
    Ward, J.
    Waqar, S.
    Morgensztern, D.
    Govindan, R.
    Devarakonda, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S209 - S210
  • [35] Heterogeneity and prognostic diagnosis of KRAS-mutated population and KRAS G12C subtype among patients (pts) with advanced NSCLC (aNSCLC): A real-world study aided by machine learning approaches
    Loong, H. H. F.
    Liu, T.
    Pattipaka, T.
    Hong, R.
    Smith, T. W.
    Knoll, S. M.
    Pretre, V.
    Bitton, R. Caparica
    Ye, F.
    Farago, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1088 - S1088
  • [36] Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary
    de Langen, Adrianus Johannes
    Johnson, Melissa L.
    Mazieres, Julien
    Dingemans, Anne-Marie C.
    Mountzios, Giannis
    Pless, Miklos
    Wolf, Juergen
    Schuler, Martin
    Lena, Herve
    Skoulidis, Ferdinandos
    Yoneshima, Yasuto
    Kim, Sang-We
    Linardou, Helena
    Novello, Silvia
    van der Wekken, Anthonie J.
    Chen, Yuanbin
    Peters, Solange
    Felip, Enriqueta
    Solomon, Benjamin J.
    Ramalingam, Suresh S.
    Dooms, Christophe
    Lindsay, Colin R.
    Ferreira, Carlos Gil
    Blais, Normand
    Obiozor, Cynthia C.
    Wang, Yang
    Mehta, Bhakti
    Varrieur, Tracy
    Ngarmchamnanrith, Gataree
    Stollenwerk, Bjoern
    Waterhouse, David
    Paz-Ares, Luis
    FUTURE ONCOLOGY, 2025,
  • [37] Safety and efficacy of D-1553 in combination with cetuximab in KRAS G12C mutated colorectal cancer (CRC): A phase II study
    Xu, R-H.
    Xu, Y.
    Yan, D.
    Munster, P.
    Ruan, D.
    Deng, Y.
    Pan, H.
    Underhill, C. R.
    Richardson, G.
    Nordman, I.
    Lee, K-W.
    Wei, S.
    Li, X.
    Shan, J.
    Han, G.
    Henderson, S.
    Xie, X.
    Xiang, Z.
    Shi, Z.
    Zhang, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S410 - S411
  • [38] Efficacy of JS']JSI-1187 or VIC-1911 in combination with KRAS G12C inhibitors for the treatment of KRAS G12C-mutated non-small cell lung cancer and colorectal cancer
    Zhang, Lei
    Li, Ao
    Jian, Shanzhong
    Du, Chengyi
    Zhu, Wan
    Tao, Yue
    Wang, Meiwei
    Xu, Wen
    Hao, Wenshan
    Paradiso, Linda
    Myers, Thomas
    Koya, Keizo
    Zhang, Jintao
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort.
    Cui, Wanyuan
    Franchini, Fanny
    Alexander, Marliese
    Officer, Ann
    Wong, Hui Li
    IJzerman, Maarten J.
    Desai, Jayesh
    Solomon, Benjamin J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Sotorasib with panitumumab in chemotherapy-refractory KRAS G12C-mutated colorectal cancer: a phase 1b trial
    Kuboki Y.
    Fakih M.
    Strickler J.
    Yaeger R.
    Masuishi T.
    Kim E.J.
    Bestvina C.M.
    Kopetz S.
    Falchook G.S.
    Langer C.
    Krauss J.
    Puri S.
    Cardona P.
    Chan E.
    Varrieur T.
    Mukundan L.
    Anderson A.
    Tran Q.
    Hong D.S.
    Nature Medicine, 2024, 30 (1) : 265 - 270
12345